Ovarian Biomarkers in Infertility by Ivailo Vangelov et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
8 
Ovarian Biomarkers in Infertility 
Ivailo Vangelov, Julieta Dineva, Krassimira Todorova, 
Soren Hayrabedyan and Maria D. Ivanova 
Institute of Biology and Immunology of Reproduction “Acad. K. Bratanov”, 
Bulgarian Academy of Sciences, 
Bulgaria 
1. Introduction 
The female infertility is a complex phenomenon that at least in part resides in the 
manifestation, possible perturbations and interplay of innate and adaptive immunity, with 
the participation of apoptotic and reactive oxygen species pathways, and some paracrine 
factors as causative and implementing factors in this process. The spread of the assisted 
reproduction technologies provided an unseen before opportunity to the intimacy of the 
ovarian follicle – the oocyte cellular surroundings and the oocyte itself, enabling research 
and medical community to boost the pursuit of new ovarian function biomarkers in the 
context of gamete fertilization and embryo development competence. The notion of 
infertility markers would be presented in a comprehensive viewpoint based on the 
importance of the folliculogenesis, oocyte-cumulus-granulosa cells interactions and oocyte 
genesis. This approach is aimed on the provision of non-invasive means for oocyte and 
embryo competence evaluation and improved reproductive medicine outcome. 
2. Autoimmunity and ovarian function impairment 
2.1 Anti-ovarian antibodies and infertility 
The human ovary can be target of an autoimmune attack in various circumstances, 
including several organ-specific or systemic autoimmune diseases. One important issue 
concerning autoimmunity and infertility is the role of autoimmune responses against ovary, 
adrenal and thyroid glands in the development of premature ovarian failure.  
Premature Ovarian Failure (POF) or Primary Ovarian Insufficiency (POI)) is the loss of 
function of the ovaries before age of 40. It has been estimated that POF affects 1% of the 
population (Chatterjee et al., 2007). Hormonally, POF is defined by abnormally low levels of 
estrogen and high levels of follicle stimulating hormone (FSH), which demonstrate that the 
ovaries are no longer responding to circulating FSH by producing estrogen and developing 
fertile oocyte.  
One of the reasons to suspect an autoimmune etiology of POF is the frequent association of 
POF with some organ-specific autoimmune diseases but the absence of associated disease 
cannot exclude an autoimmune mechanism. Among organ - specific autoimmune diseases, 
the thyroid and adrenal diseases (Addison's disease) are frequently associated with POF. In 
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regard to association with adrenal autoimmunity (Addison’s disease) three different 
situations have to be distinguished: POF associated with adrenal autoimmunity, POF 
associated with nonadrenal autoimmunity, and isolated or idiopathic POF (Forges et al., 2004). 
Among POF patients with adrenal autoimmunity 4–5% are positive for autoantibodies 
directed against steroidogenic cytochrome P450 enzymes, such as 21-hydroxylase 
autoantibodies, 17ǂ-hydroxylase autoantibodies and cholesterol side-chain cleavage enzyme 
(side-chain cleavage autoantibodies or steroid cell autoantibodies, SCAs)(Chen et al., 1996). 
Positivity for these autoantibodies identifies POF due to autoimmunity to steroid-producing 
cells - SCA-POF (Hoek et al., 1997, Betterle et al., 2002, Bakalov et al., 2005). In these patients 
the ovarian pathology has been associated with selective mononuclear cell infiltration of large 
antral follicles (Hoek et al., 1997) and with autoimmune destruction of theca cells (Welt et al 
2005). The autoimmune damage of the ovarian theca cells and adrenal cortex are thought to 
be a T cell-mediated process (Hoek et al., 1997) as POF patients with adrenal autoimmunity 
have predominantly expressed IgG1 isotype SCA (Brozzetti et al., 2010). The predominant 
IgG1 isotype of the specific autoantibodies can be interpreted as a sign of Th1 immune 
response (Hawa et al., 2000). The presence of SCA is a risk factor for development of POF. 
Relatively higher percentage of women with normal menstrual cycle, who have 
polyendocrinopathy and SCA become susceptible to ovarian failure development within 8–
15 years). The pathophysiological significance of SCA seems to be restricted to patients 
whose ovarian failure is associated with adrenal autoimmunity. These antibodies are very 
useful markers of ovarian failure in Addison’s disease patients. In 90% of these patients at 
least one type of SCA can be detected (Falorni et al., 2002) whereas the prevalence of SCA in 
<10% of cases has been detected in the patients with POF associated with nonadrenal 
autoimmunity and in the patients with idiopathic POF (Dal Pra et al., 2003). 
On the other hand, two-thirds of women with recently diagnosed POF due to SCA- 
associated autoimmunity have normal serum Anti-Müllerian hormone (AMH) 
concentrations (La Marca et al., 2010). AMH is expressed by granulose luteinized cells 
(GLCs) of the ovary during the reproductive years, and controls the formation of primary 
follicles by inhibiting excessive follicular recruitment by FSH. It therefore, has a role in 
folliculogenesis and some authors suggest it is a measure of certain aspects of ovarian 
function (Broer 2011) and useful in assessing conditions such as polycystic ovary syndrome 
(PCOS) and POF. However, the normal AMH levels in women recently diagnosed for SCA-
POF imply that this form of ovarian failure have association with a preserved pool of 
functioning follicles (La Marca et al., 2010). Indeed, in such patients this is selective 
autoimmune destruction of theca cells with preservation of GLCs that produce low amounts 
of estradiol because of lack of substrates. Therefore, the more exact term of this 
complication, as well as other forms of ovarian failure, would be primary ovarian 
insufficiency (POI) (Nelson 2009), since the term POI implies more appropriately the 
continuous nature of the impaired ovarian function. 
Among systemic autoimmune diseases, the systemic lupus erithemathosus (SLE) is thought 
to be most frequently associated with POF (Hoek et al., 1997). Anti- corpus luteum 
antibodies could represent the first stage of altered ovarian function in SLE patients (Pasoto 
et al., 1999). An autoantigenic 67 kDa target recognized by autoantibodies from 22% of 
patients (age<40) with SLE has been described to correlate with elevated serum FSH levels. 
In general, anti ovarian antibodies (AOA) were found in 84% of the cases of female SLE 
patients (Moncayo-Naveda et al., 1989).   
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Follicle dysfunction could be associated with inadequate follicular function, for example, 
due to mutated FSH- receptor gene (Doherty et al., 2002), but also due to autoimmune 
ovarian disease damaging the maturing follicles, but at the same time leaving the primordial 
follicles intact. In the majority of the cases, the cause of POF is unknown, but some of the 
causes can lead to absence of oocytes, whereas others can lead to disordered follicle 
maturation. However, several studies have suggested that some cases of POF could be a 
direct result of autoimmune-mediated damage of the ovaries (Hoek et al., 1997). 
Strong support for an autoimmune character of isolated POF would be the presence of 
antibodies to ovarian structures or AOA in the serum of these patients. Evidence favors the 
presence of an autoimmune disease of the ovary. In some cases AOA has been considered to 
be a suitable marker for identification of autoimmune POF (Luborsky et al., 1990, 2000, 
Fénichel et al 1997, Pires et al., 2006) as well as immunological- related infertility in “in vitro” 
fertilization (IVF) patients (Gobert et al., 1992, Ivanova et al. 1994, 1999, Barbarino-Monnier 
et al., 2003, Pires et al, 2007). Screen for the presence of AOA before the initiation of the IVF 
cycle could be recommended, since AOA are thought to be associated with poor results in 
infertility patients included in the programs for assisted reproduction (Pires et al., 2007). 
Other ovarian disturbances as Polycystic Ovarian Syndrome (PCOS), endometriosis, and 
unexplained infertility are associated with anti-ovarian autoimmunity. Approximately 15% 
to 30% of couples will be diagnosed with unexplained infertility after their diagnostic 
workup (Practice Committee of the American Society for Reproductive Medicine, 2006). The 
presence of AOA has been detected in patients with unexplained infertility (Luborsky et., al 
1999, 2000, 2002). It has been demonstrated that AOA could be detected several months or 
years before the onset of the clinical symptoms without affecting the serum FSH or inhibin B 
levels (Luborsky et al 2000). Collectively these findings suggest that the AOA are 
independent markers for the future onset of ovarian failure. 
PCOS is of clinical and public health importance as it is very common, affecting up to one in 
five women of reproductive age. The prevalence of PCOS depends on the choice of 
diagnostic criteria. One community-based prevalence study using the Rotterdam criteria 
found that about 18% of women had PCOS, and that 70% of them were previously 
undiagnosed (Teede et al., 2010). The association of ovarian autoimmunity with PCOS has 
been previously evaluated (Luborsky et al., 1999). It has been found that the frequency of 
AOA is similar (25%) among the normally cycling women and PCOS patients. The possible 
development of humoral autoimmunity and production of AOA consequent to ovarian 
damage has also been determined in clomiphene citrate-resistant PCOS patients (Alborzi et 
al., 2009).  
Autoimmunity to endometrium and ovary has been studied in patients with endometriosis 
(Mathur et al., 1982). It has been demonstrated the presence of elevated autoantibody titers 
to whole ovary, theca cells, granulosa cells and endometrium in the patient sera, and to 
GLCs in the cervical secretions. Endometriosis and PCOS have been associated with higher 
values of anti-FSH IgA autoantibodies, and endometriosis also has association with anti-
FSH IgG autoantibodies). One of the major epitopes identified was a 78-93 amino acid 
sequence belonging to part of the human FSH beta-chain (Gobert et al., 2001). This 
autoantigenic determinant is recognized most frequently by human serum samples from 
women with AOA. Anti-FSH are thought to be naturally occurring autoantibodies 
associated with peripheral FSH concentrations, but increased in infertile women with 
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dysregulation of immune reactions and repeatedly performed in vitro fertilization (IVF) 
(Haller et al., 2005). 
Significant progress was made towards the identification of candidate biomarkers involved 
in human ovarian autoimmunity. The presence of anti-oocyte antibodies has been 
demonstrated in the sera of POF patients (Damewood et al., 1986) with or without 
associated autoimmune diseases (Luborsky et al., 1990) and in the sera of infertile patients 
(Pires et al., 2006, 2007), as well as in mice after neonatal thymectomy (Tong & Nelson 1999). 
In the mouse model of autoimmune ovarian failure, the autoantigenic oocyte protein has 
been identified and called Maternal Antigen That Embryos Require (MATER), (Tong & 
Nelson, 1999). Using specific and sensitive immunoassays (Pires et al., 2007) demonstrated 
that AOA in infertile women identified an immunodominant antigen- heat shock protein 90-
beta, which was localized predominantly in the oocyte cytoplasm. Therefore, anti-HSP90 
antibodies could be used as one of the diagnostic markers for ovarian failure and thereby 
infertility (Pires et al., 2007).  
Anti-Zona pellucida autoantibodies bind to the oocyte Zona pellucida (ZP), and therefore, 
could prevent sperm-zona interaction (Kyurkchiev et al., 1988, Barber & Fayrer Hosken, 
2000). Zona pellucida proteins play critical role in oocyte fertilization. Anti-ZP 
autoantibodies have been linked with human female infertility (Ivanova et al.1994, 1999, 
Mardesic et al., 2000, Kelkar et al., 2005, Koyama, 2010). Intra cytoplasmic sperm injection 
(ICSI) is recommended option for IVF therapy of women with anti-ZP autoantibodies 
(Mardesic et al., 2000). Anti- ZP autoantibodies may induce autoimmune-mediated ovarian 
damage with follicular depletion and fertility suppression due to impaired ZP formation 
(Lloyd et al., 2010) and disruption of the gap junctions between the oocyte and granulosa 
cells, damaging the bidirectional communication necessary for normal folliculogenesis 
(Calongos et al., 2009).  
In addition, novel immunotherapy strategy has been proposed recently for treatment of 
autoimmune ovarian disease (Li et al., 2008). The continuous presence of physiologically-
expressed autoantigen is critical for both tolerance maintenance and autoimmune disease 
pathogenesis, thus the outcome is determined by the integrity of regulatory T cells, whereas 
deficiency in the regulatory T-cell function is associated with elevated responsiveness to 
autoantigen and to environmental stimuli that could potentially promote the autoimmune 
disease and memory (Tung et al., 2005). Sundblad et al., 2006 showed the presence of 
circulating autoantibodies directed towards an antigen of approximately 50 kDa, identified 
subsequently as alpha-enolase. It has been demonstrated that 21 of 110 women with 
autoimmune POF express this autoantibody, whereas 60 control subjects proved negative. 
Aldehyde (retinal) dehydrogenase 1A1 (ALDH1A1) and selenium-binding protein 1 (SBP1) 
are identified as unique autoantigenic targets associated with unexplained infertility 
(Edassery et al., 2010). 
More recently, three immunodominant ovarian autoantigens, ǂ-actinin 4 (ǂACTN4), heat 
shock 70 protein 5 (HSPA5) and ǃ-actin (ACTB), have been identified using AOA -positive 
sera from women with idiopathic POF and women undergoing IVF (Mande et al., 2011). 
These autoantigens are localized in different structures of the ovary such as the ooplasm of 
the oocyte, theca, granulosa, corpus luteum and zona pellucida. All the above antigens were 
found to be expressed in the ooplasm throughout follicular development, and all of them 
were expressed specifically in the oocyte except ǂACTN4. Both women with infertility and 
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those with ovarian cancer have autoantibodies to ovarian antigens. Luborsky et al., 2011 
showed for the first time that antibodies to mesothelin, a well-characterized ovarian cancer 
antigen, occur in some of the women with epidemiologic risk for ovarian cancer.  
The antibody-mediated autoreactivity directed towards the granulosa cells has been 
reported in the sera of POF patients (Damewood et al., 1986, Kelkar et al., 2005). AOA in 
POF patients showed immunoreactivity against the granulosa cells from both the pre-antral 
and the antral follicles (Damewood et al., 1986). In small percentage of the anti-ZP positive 
POF sera, a strong autoreactivity directed to granulosa cells has also been detected (Horejsi 
et al., 2000, Kelkar et al 2005). A 51 kDa protein has been identified as an additional target of 
SCA (Winqvist et al., 1998). It has been localized in the placenta and in the GLCs by the sera 
of patients with adrenal insufficiency and associated ovarian failure. 
We have developed an ELISA assay to assess the prevalence of anti-granulosa cell 
antibodies and we have estimated it to be 28.7% in the sera and 44.90 % in the follicular 
fluids (FFls) of infertile patients undergoing controlled ovarian hyper-stimulations (COHS) 
for IVF-ET (embryo transfer) compared to 9.1% and 6.67% in the fertile women sera and FFls 
respectively (Vangelov et al., 2005,2006,2009).For the isolation of granulosa cells, pooled 
follicular fluids were collected individually for each patient, centrifuged at 200 x g and purified 
using HISTOPAQUE® -1077 (Sigma Diagnostics, Inc.) gradient centrifugation approach (for 
details, see Vangelov et al., 2005). The results obtained by this ELISA assay disclosed that 
antibodies against granulosa cell-antigens occurred more frequently in infertile women 
undergoing IVF-ET than in fertile normally menstruating women (controls) at the same age, 
inferring to the conclusion that the detection of anti-granulosa cell antibodies serve as an 
indicator for their involvement in immunological infertility. Auto-antibodies against GLCs 
antigens may be considered as a part of the heterogeneous group of AOA (Ghazeeri & Kutteh 
2001). The prevalence of anti-granulosa cell autoantibodies in the subgroup with low 
fertilization rate suggests a negative impact of the anti-granulosa cell autoantibodies on the 
fertilization outcome. It was suggested that the binding of these antibodies to follicular cells 
might be a defective signal in the fertilization process (Horejsi et al., 2000). Anti-granulosa 
cell autoantibodies could play a role as a marker of fertilization failure. 
In addition to the mentioned above, the identification of putative granulosa cell antigens 
recognizable by the antibodies in the infertile women sera, but not by the fertile controls sera 
is of huge importance. Four undefined GLC autoantigens - 110 kD, 70-80 kD, 47 kD and 37 
kD have been identified as autoantigenic targets for the anti-GLCs autoantibodies using 
immunoblotting assay developed by us (Vangelov et al., 2005). The results from 
immunoblotting revealed that: 3 patient’s sera and none control sera reacted with protein 
band with MM 37 kD; 14 patient’s sera and 3 control sera - at 47 kD; 10 patient’s sera and 1 
control serum - at 70-80 kD and 8 patient’s sera and 3 control sera - at 110 kD. Four patient’s 
sera reacted with all above protein bands. The band with approximate MM of 47 kD was the 
most frequently occurring antigen in infertile women and the band of 37 kD reacted only 
with sera from infertile patients studied.  
2.2 Cellular immunity, pro-inflammatory cytokines and apoptosis in infertility 
The diagnosis of an autoimmune mechanism involvement in infertile patients relies not only 
on the presence of autoantibodies directed to ovary, but also on the dynamics of immune 
cell populations and their soluble products. Natural killer cells (NK cells) constitute a major 
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component of the innate immune system. NK cells have a suppressive action on B cells, and 
therefore, the impaired NK cell activity has a role in some types of autoimmunity. NK cell 
abnormalities have been reported in women with POF (Hoek et al., 1995) and in women 
with POI (van Kasteren et al., 2000), as well as in murine post-thymectomy autoimmune 
oophoritis (Maity et al 1997), all demonstrating a decreased NK cell number and/or activity. 
Similarly NK cells suppression is observed in neonatal thymectomy induced mice 
autoimmune oophoritis (Maity et al., 1997), while treatment by the NK cell-stimulating 
factor (IL-12) before thymectomy preserves the NK cell activity and ameliorates the 
associated autoimmune oophoritis. NK cells produce the signature Th1 cytokine IFN-Ǆ. The 
increased periphery NK cell activity and number during pregnancy might explain the 
apparent Th1 bias (Ntrivalas et al., 2001) that is also associated with multiple observations of 
recurrent pregnancy losses (Piccinni et al., 1998, Prado-Drayer et al., 2008). These findings 
suggested an important role for the innate immune system. The immune activation might 
cause pregnancy failure by inhibiting the reproductive endocrine system. In this way, for 
example, the inflammatory cytokines are thought to inhibit both the gonadotropin 
production at hypothalamus and pituitary gland level (Rivest & Rivier 1995), and the 
progesterone synthesis in corpus luteum of the ovary as well as to promote the luteal 
regression (Davis & Rueda 2002). Monocytes (Mo) and the monocyte-derived dendritic cells 
(DCs) play a prominent role in the initial stages of autoimmune reactions against endocrine 
organs. The accumulation of monocytes/DCs and the clustering of DCs in endocrine organs 
is one of the first sign of an autoimmune endocrine disorder. Mo start to replace the resident 
Macrophages (Ma) and DCs under normal state and in response to inflammation signals, 
they move in the tissue vicinities and proliferate and differentiate into Ma and DCs. The 
main function of DCs is to act as antigen presenting cells, being messengers between the 
innate and adaptive immunity. Immature DCs are found in the bloodstream, but once 
activated, they migrate to the lymph nodes where they interact with T- and B -cells to 
initiate and shape the adaptive immune response. Dysfunction of Mo and DCs has been 
found in patients with ovarian failure (Hoek et al., 1993) long enough - the Mo have 
abnormal polarization and DCs have abnormal interaction with T -cells, refractive to 
estrogen substitution correction. Alteration of T cell subsets and T cell mediated injury is 
likely to play an important role in pathogenesis of autoimmune ovarian failure as evidenced 
by human studies and animal models of autoimmune oophoritis (Hoek et al., 1995, Mignot 
et al., 1989b, van Kasteren et al., 2000, Chernyshov et al., 2001). The hypoestrogenic hormone 
status in ovarian failure patients could be responsible for the elevated numbers of activated 
blood T cells. It has been demonstrated that the estrogen substitution lowered the number of 
activated peripheral T cells in ovarian failure patients, although not to completely normal 
levels (Hoek et al 1995). Despite the fact that the data on the numbers of T cells vary 
between the reported studies, a consistent pattern of an increased number of activated 
(MHC II+ or IL-2R+) T cells have been demonstrated in the majority of the studies (Hoek et 
al., 1997). Elevation in the number of peripheral blood B cells has been reported in patients 
with ovarian failure (Ho et al., 1988), and in ovarian failure patients during initial period of 
disease (Chernyshov et al., 2001), and in patients with primary ovarian insufficiency (van 
Kasteren et al., 2000), and in murine autoimmune ovarian failure (Ivanova et al., 1984), and 
relationship of the raised numbers of B cells to the presence of various autoantibodies has 
been also demonstrated (Ho et al., 1988). The elevated numbers of peripheral blood B cells is 
thought to be a sign of activation of the humoral immune system, which is crucial for 
autoantibody production. This can be very important because estrogen substitution in 
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patients with ovarian failure did not lower the elevated number of peripheral B cells (Hoek 
et al., 1995). Similar immunological profile has been shown in patients with POI and in 
patients with POF (van Kasteren et al., 2000), suggesting that POI is a light form of POF. It 
has been found a decrease in NK cells and in percentage of T-suppressor cells with a rise in 
T-helper/T-suppressor cell ratio, as well as an increase in B- cells and HLA-DR+ T cells. The 
question remains whether these changes are the cause or the consequence of the ovarian 
failure. Autoimmune damage of the ovary could be the primary cause of POF, whereas in 
natural menopause autoimmunity is a result of hormone dysfunction (Chernyshov et al., 
2001). 
The variations of cellular immunity function and its relationship with AOA (Huang et al., 
1996) and with anti-granulosa cells autoantibodies (Vangelov et al., 2009) have been 
investigated in patients with ovarian failure. The patients with ovarian failure have 
increased AOA, CD4+ T-cells and CD4+/CD8+ ratio. It has been shown also, that AOA 
positive rate in POF patients is associated with higher CD4+/CD8+ ratio (Huang et al., 
1996). 
In our study, we used our propriate granulosa cell autoantibody ELISA detection assay, and 
commercially available TNF-ǂ and IFN-Ǆ ELISA kits (eBioscience, USA) to estimate the 
abundance of granulosa cell autoantibodies, and the concentrations of TNF-ǂ and IFN-Ǆ in 
FFls, as well as DNA-DAPI staining for the assessment of granulosa cells apoptotic index in 
ovarian failure patients. The obtained results reveled several findings: 1) significantly higher 
levels of IFN-Ǆ, TNF-ǂ and apoptotic cells in women with positive autoantibody ELISA test, 
and 2) significant correlation of anti- granulosa autoantibodies, and apoptotic index, as well 
as significant correlation of IFN-Ǆ with TNF-ǂ and apoptotic index. Moreover, we have 
reported (Vangelov et al., 2008, 2009), that cellular immunity (TNF-ǂ, IFN-Ǆ) and humoral 
immunity (anti-granulosa cell autoantibodies) to granulosa autoantigens can be 
concurrently produced in patients with ovarian failure, and we suggested that pathogenesis 
of ovarian failure may be associated with immune factors and apoptosis of granulosa cells. 
In this scenario the programmed cell dead (apoptosis) of granulosa cells could be very 
important player. The ovulatory process represents the classical sequence of an acute sterile 
inflammation under surveillance of innate immune function (Medzhitov, 2010, Rock et al 
2010). The cell damage is associated with the release of danger signals-alarmins (Bianchi 
2007). In the preovulatory follicle main source of danger signals are damaged granulosa 
cells (Spanel-Borowski 2011) and the danger signals could be recognized by 
CK+(cytokeratin-positive) granulosa cells via TLR-4 or other pattern-recognition receptors 
(PRRs) (Serke et al., 2009, 2010). The ovarian innate immune function will be activated to 
orchestrate the ovulatory process (Spanel-Borowski, 2011). CK+ cells are assumed to switch 
off the CK genes in the corpus luteum (CL) stage of secretion and regression to become 
granulosa-like cells. The granulosa-like cells are thought to be mature DC in the CL (Spanel-
Borowski, 2011). However, the low T cell number in the preovulatory follicle wall is 
signature for a limited interaction with the adaptive immunity. A disturbed conversation 
between innate and adaptive immunity is reflected by altered T cell profiles in the FFls of 
patients with idiopathic infertility and in ovaries with POF due to autoimmune damage 
(Vujovic 2009, Spanel-Borowski 2011). Because DCs process antigens and train naive T cells 
to become helper and suppressor cells (Banchereau & Steinman, 1998, Turvey & Broide, 
2010), DCs are players between innate and adaptive immunity. The pathway of innate 
immunity is well balanced to achieve the quick recovery of tissue integrity, but an 
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unbalanced action can cause chronic tissue injury and autoimmune diseases. In this aspect, 
we have reported the relationship between the level of apoptotic granulosa cells and the 
level of anti- granulosa cell autoantibodies in studied patient group with ovarian failure 
(Vangelov et al., 2009). Moreover, the biomolecules are susceptible to glycosylation, 
glycation, phosphorylation and oxidation. Oxidative stress is the major event causing 
structural modification of proteins with consequent appearance of neo-epitopes (Buttari et 
al., 2005). The role for oxidative stress in promoting the autoimmune responses have been 
reviewed (Kannan 2006). Autoimmune responses may be directed against self-structures 
altered by high-affinity ligand binding or by chemical damage due to environmental events, 
such as oxidative stress. Several systems that generate reactive oxygen species catalyze a 
variety of oxidative damage to nucleic acids, lipids, and proteins. In physiological 
conditions oxidative stress is well compensated, but when there is an overproduction of 
reactive oxygen species or a deficiency of antioxidant enzyme activity, a biological damage 
may occur (Puddu et al., 2009). Oxidative stress and inflammation may determine the 
modification of self-structures also favoring the formation of Advanced glycation end 
products (AGEs). Chronic oxidative stress causes an accumulation of AGFs products 
(Ramasamy et al., 2009). The generation of AFGs products and augmentation of 
proinflammatory mechanisms provide a potent feedback loop for sustained oxidant stress, 
ongoing the generation of AFGs products. Therefore, self-molecules modified by oxidative 
events can become targets of autoimmune reactions, thus sustaining the inflammatory 
responses. In another hand, the disturbed apoptosis execution and clearance can potentially 
render apoptotic cells as a source of autoantigens normally sequestered in the intracellular 
environment. Structural changes occurring during cell death may influence the 
immunogenicity of clustered self-antigens at the surface of apoptotic body (Navratil et al., 
2005). In this scenario, high concentrations of self-antigens are packaged during generation 
of apoptotic cells; the packages also may contain altered fragments of self-antigens that have 
not been encountered previously by the immune system; under normal circumstances, 
apoptotic cells are cleared rapidly by macrophages and DCs; therefore, the apoptosis-altered 
self-antigens are either ignored by the immune system or tolerance to those antigens is 
maintained. Clearance is achieved through complex mechanisms that enable macrophages 
and DCs to recognize apoptotic cells as nonthreatening "self" particles, but defects in this 
process that cause a delay in clearance could change the appearance of apoptotic cells and 
cause them to be recognized as "foreign invaders," thereby stimulating an inflammatory 
response that, in turn, activates an immune response to self-antigens (Navratil et al., 2005). 
The ovary is an extremely dynamic organ in which excessive or defective follicles are 
rapidly and effectively eliminated throughout reproductive life. Greater than 99 % of 
follicles disappear, due to apoptosis of granulosa cells. The balance between signals for cell 
death and survival determines the destiny of the follicles. The potential use of scores for 
apoptosis in granulosa cells and characteristics of FFls have been discussed more recently as 
prognostic markers for predicting the outcome of assisted reproduction (Lefèvre et al., 2011). 
Follicular fluid and surrounding tissue contains various lymphocytes that synthesize 
different cytokines. The other sources of cytokines are ovarian somatic cells. We studed the 
impact of proinflamatory cytokines TNF-ǂ and IFN-Ǆ concentration in FFls, and apoptotic 
index of granulosa cells on the results of COH/IVF in women with ovarian failure 
(Vangelov et al., 2009). The obtained results in this study clearly showed that the elevated 
levels of TNF-ǂ and IFN-Ǆ were directly related with increased incidences of apoptotic 
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granulosa cells and altogether were associated with poor COH/IVF outcome. Moreover, 
earlier Cianci et al., 1996 reported association of elevated concentration of TNF-ǂ with 
reduced fertilization rate in women with immunological infertility and concluded, that the 
elevated TNF-ǂ concentration in the human follicle may negatively influence both ovulation 
and fertilization related events. 
3. Intra ovarian regulators of survival and apoptosis in preovulatory follicle 
3.1 Apoptosis of granulosa luteinized cells (GLCs) and cumulus cells (CCs) – 
predictive marker for results of COH / IVF outcome in infertile women 
The oocyte-cumulus-granulosa cells unit comprises an intimate relation between somatic 
cell syncytium in conjunction with the oocyte involving gap junctions and complex of 
hormonal and peptide factors. Granulosa cells and cumulus cells play a critical role in 
oocyte maturation and fertilization by releasing and mediating signals to oocytes. On the 
other hand the oocyte also influences granulosa cells steroidogenesis, proliferation and 
Hyaluronic acid synthesis by CCs. Each participant in this unit can disturb signaling and 
regulation of apoptotic process. Apoptosis is self-destruction under physiological control 
and is closely involved with most of the reproductive processes, including follicular atresia. 
Apoptosis can be used to estimate a function of ovarian reserve in women undergoing IVF 
(Seifer et al., 1996). Many studies have provided evidence that poor oocyte, low IVF 
outcome and embryo quality can be associated with apoptosis. The incidence of apoptotic 
bodies has been used as a morphological marker for physiological cell renewal (Tilly et al., 
1991) and the presence of apoptosis in human GLCs and CCs in COHS during IVF 
treatment, has been used as a very sensitive indicator for evaluation of oocyte quality and 
the IVF outcome (Nakahara et al., 1997; Suh et al., 2002). 
The isolated GLCs (Vangelov et al., 2005) were fixed with formaldehyde. The GLCs 
suspensions were dropped on poly L-Lysine treated slides. CCs were isolated from 
individual cumulus-oocyte complexes (COCs) of the same patients, and were divided 
according to the oocyte maturation (immature – G.V. or MI or mature – MII oocytes). The 
cumulus masses were dispersed with 150 IU Hyaluronidase and after that were fixed and 
processed as GLCs.  
Apoptosis of GLCs and CCs was assayed using DNA-DAPI staining (Dineva et al., 2006) 
that allows the observation of morphological changes of nuclear chromatin in GLCs and 
CCs. Morphological characteristics of apoptosis such as chromatin condensation and/or 
nuclear fragmentation were identified and counted in randomly selected fields among 800–
1000 cells and the percentage of apoptotic cells was calculated. The significant negative 
correlations between the rate of apoptosis in GLCs and both - the number of preovulatory 
follicles, and the number of retrieved and fertilized oocytes from patients in stimulated 
cycles was found.  
The most convenient evaluation system for oocyte quality is based on oocyte morphology 
and status of oocytes–cumulus complexes. Cumulus cells surround and intercommunicate 
with oocytes during follicular development and after ovulation, suggesting that the 
incidence of apoptosis in cumulus cells could influence oocyte quality (Lee et al., 2001). In 
our study we found that the rate of apoptosis in GLCs is higher compared to CCs cells from 
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the same patient. The higher rate of apoptosis in CCs from follicles with immature oocytes 
than from those with mature showed that the level of CCs apoptosis is directly related to the 
maturation of oocytes and support the data of Host et al., 2000.  
The obtained results showed that the incidence of apoptosis in GLCs as well as in CCs could 
be a predictive marker for IVF outcome. 
3.2 Role of Atrial Natriuretic Peptide (ANP) in the ovarian immunoendorine function 
3.2.1 GLCs are the main local source of ANP in the preovulatory human follicle 
Many endocrine, paracrine and autocrine factors (gonadotrophic and steroid hormones, 
peptide hormones, cytokines, highly- reactive free radicals) play an important role in the 
regulation of GLCs proliferation, differentiation and death.  
The expression of natriuretic peptides (NPs) and its receptors (NPRs) has been 
demonstrated in the mammalian ovary (Gutkowska et al., 1993; Russinova et al., 2001).  
The presence of ANP was demonstrated in the follicular fluid (Kim et al., 1987); granulosa cells 
(Ivanova et al., 2003) and luteal cells (Vollmar et al., 1988). ANP plays an important role in the 
regulation of different aspects of ovarian physiology, such as oocyte meiosis, cumulus cells 
expansion, spontaneous oocyte maturation, ovarian steroidogenesis and follicular atresia 
(Samson WK et al., 1988, Tornel et al., 1990; Gutkowska et al., 1999; Zhang et al., 2005). 
The indirect immunofluorescence technique (IIF) was used to investigate the localization 
patterns of ANP on GLCs isolated from women undergoing IVF. The isolated GLCs were 
fixed on the protocols mentioned above. The GLCs suspensions were dropped on poly L-
Lysine treated slides. The cells were permeabilized with Triton X-100 for 5 min and after 
washing the cells were incubated with cocktail of monoclonal antibodies (Mabs) against 
recombinant human ANP (Mabs: 6C3, 6F11, 5D3 supernatants), obtained and characterized 
at the Department of Molecular Immunology (Institute of Biology and Immunology of 
reproduction, Sofia, Bulgaria), diluted 1:1 in PBS/BSA, overnight, followed by washing with 
PBS-Tween 20 and then incubated with secondary antibody (Sw/am IgG labeled with FITC, 
Sevac, Czech Republic), diluted 1:20, for 1h. After washing in PBS-Tween 20, slides were 
mounted with Mowiol (Sigma®). The expression and localization of ANP were examined 
using fluorescence microscope (Leiz Labor-Lux, Zeiss). The immunofluorescent expression 
level of ANP was scored as the intensity of specific immunofluorescence and the number of 
positive cells from (+) to (+++) as follows: (+++) – intensive immunoreactive ANP 
expression in prevailing cells population; (++) - intensive immunoreactive ANP expression 
in most of cells observed; (+) – intensive expression of immunoreactive ANP in a minority of 
cells observed. 
ANP expression was observed as membrane, submembrane and particular granular 
cytoplasm localized staining. The mature ANP is generated by proteolytic processing in two 
steps: generation of pro-ANP (stored in the cytoplasmic granules) from immature pre-pro 
ANP (Bloch et al., 1985), followed by proteolytic maturation of pro-ANP to mature bioactive 
ANP (Schwartz et al., 1984). The bioactive ANP gets into extracellular space and in this 
manner ANP acts as autocrine and/or paracrine factor that modulates different aspects of 
GLCs functions. We consider that the different patterns of ANP expression in GLCs 
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represent localization of ANP during the different stages of posttranslational processing 
and/or export of ANP from GLCs. 
The women included in this study were divided into two groups: women with high level of 
ANP expression and women with low level of ANP expression in GLCs.  
For us the question of great interest was, whether the GLCs are the principal source of ANP 
in the human preovulatory follicle? For this reason, we measured the ANP concentrations in 
FFl obtained from the same woman that donated the GLCs specimens followed by an 
analysis of relationship between the follicular ANP concentration and the expression levels 
of immunoreactive ANP in GLCs. The concentration of ANP was measured in FFls, 
obtained from the same woman using a proANP (1-98) kit, with levels of immunoreactive 
ANP in GLCs found positively correlating to the corresponding FFls ANP concentrations. 
The concentration of ANP in the FFls of women with high level of immunoreactive ANP 
expression in GLCs was found to be significantly higher, compared to the women with low 
level of ANP expression in GLCs. 
Our earlier study showed that, in in vitro luteinized porcine granulosa cells (isolated from 
prepubertal porcine ovaries) supplemented with FSH and luteinizing hormone (LH), the 
expression of immunoreactive ANP was increased and was highest among the FSH and LH 
treated GLCs (Dineva et al., 2007).  
The established positive relationship between the levels of ANP in FFls and its 
immunoreactive expression on GLCs together with findings of in vitro experiment show 
that the GLCs are the main local source of ANP in the preovulatory human follicle. 
3.3 ANP is survival factor for GLCs in preovulatory follicle 
Diverse effects of NPs are mediated by the activation of membrane bound receptors with a 
particulate guanylate cyclase (GC) activity to generate Cyclic Guanosine Monophosphate 
(cGMP). The physiological activities of ANP are mediated by a specific plasma membrane 
receptor, guanylate cyclase-type receptor GC-A (Chang et al., 1989). Recent studies have 
shown that components of cGMP signaling pathways are expressed in the ovary and that 
cGMP can alter granulosa cell function (La Polt et al., 2003). The cGMP/PKG signaling is a 
target for the prevention of mitochondrial dysfunction-mediated cell death (Chun SY et al. 
1996, Takuma et al. 2001).  
The survival role of ANP for GLCs, was studied in cultured human GLCs treated with 2Bu-
cGMP (analog of cGMP, Sigma) and with human recombinant ANP (hrANP, Sigma). The 
higher level of ANP production (after 2Bu-cGMP treatment) and the supplementation of 
cultured GLCs with hrANP were associated with significant suppression of Caspase-3 
activity, that is to say, with the inhibition of apoptosis in GLCs, compared to control cells. 
For Caspase-3 activity assay, the cultured cells were lysed and the soluble fraction of the cell 
lysate was assayed using specific substrate (Dineva et al., 2007) 
3.4 Role of ANP for folliculogenesis and results of COH/IVF 
ANP can affect oocyte maturation via cGMP signaling pathways, and suppress spontaneous 
oocyte maturation (Zhang et al., 2005) and in this manner ANP may be the factor which 
determines the development of fertilizable oocytes. We analyzed the relationship between 
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the concentrations of ANP in FFls obtained from women undergoing IVF with the number 
of punctured follicles and the number of retrieved oocytes (results of COH), as well as with 
the number of fertilized oocytes (results of IVF). The significant positive correlation of 
follicular ANP with the number of punctured follicles, the number of retrieved oocytes and 
with the number of fertilized oocytes were documented. Data analysis showed that the level 
of expression of ANP in the GLCs and its concentration in FFls are potential prognostic 
markers for COH/IVF outcome. 
The higher levels of ANP were associated with “good” folliculogenesis (a high number of 
punctured follicles and a high number of oocytes retrieved) and with the development of 
fertilizable oocytes (high number of fertilized oocytes), as a consequence of its direct actions 
on somatic cells and on oocytes and of its role as a survival factor in the preovulatory 
human follicle. 
3.5 Immunomodulatory role of ANP in preovulatory follicle 
In the ovary, many cytokines play an important role in regulation of ovarian 
steroidogenesis, corpus luteum formation and function, and ovulation (Adashi, 1990). Atrial 
natriuretic peptide expression from different components of immune system had 
demonstrated (Kiemer et al., 2000). Macrophages are capable to synthesize ANP and its 
active state are associated with elevate level of ANP production (Vollmar & Schulz, 1995). 
Many data showed, that resident ovarian white blood cells are in situ immunomodulator of 
processes realize in the ovarian follicle, specially ovulation, an inflammatory-like processes, 
in which immune cells, including macrophages, play very important role (Bukulmez & 
Arici, 2000, Richards et al., 2002 ).  
The immunomodulatory effect of ANP was studied on in vitro model of peripheral blood 
cells. Whole human peripheral blood samples, obtained from at least three healthy women, 
were used for in vitro culture preparation. The cytokine production in all blood samples was 
stimulated by lipopolysacharide (LPS). The rest cells were treated with human recombinant 
ANP in different concentration from 10-6 to 10-8M. The part of cells was treated with 10-12M 
ANP, concentration of ANP measured in FFls obtained of women undergoing IVF 
procedure.  
The concentrations of proinflammatory cytokines, TNF-ǂ and IFN-Ǆ in plasma samples, 
were determined by sandwich-based TNF-ǂ and IFN-Ǆ kits, respectively (E-Bioscience).  
The obtained results showed that ANP dose dependently inhibits synthesis of TNF-ǂ and 
IFN-Ǆ. The inhibitory effect of ANP on the TNF-ǂ and IFN-Ǆ, increases with the decreases of 
its concentration and is most pronounced at concentrations of ANP (10-8M and 10-12M), 
established in FFls. 
The level of transcription and synthesis of TNF-ǂ is controlled by two factors: Activation 
protein 1 (AP-1) and Nuclear factor kappa B (NF-κB) (Rhoades et al.,1992), and ANP inhibits 
their activation by cGMP mediated pathways (Tsukagoshi et al., 2001; Kiemer & Vollmar, 
2001). Furthermore, NF-κB and Nuclear Factor of Activated T cells (NFAT) control 
transcription of the gene for IFN-Ǆ and hence the synthesis IFN-Ǆ (Sica et al., 1997). The ANP 
inhibits the activation of NF-κB in cells and tissues which is important for the release of 
many inflammatory molecules and inflammatory response (Zhang et al., 2008). These data 
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and obtained results by us showed that ANP is an important intra ovarian regulator of 
inflammatory response and is a potential modulator of immune environment within 
preovulatory follicle. 
3.6 Role of antioxidant enzymes in ovarian function 
3.6.1 Survival role of Superoxide dismutase (SOD) and Catalase (CAT) for GLCs  
Physiological processes in the ovary have a dynamic character and are accompanied with 
the change in the intensity of cellular metabolism and cellular oxygen consumption, 
resulting in the generation of reactive oxygen compounds (ROS, reactive oxygen species). 
The protection from ROS is realized by both: low molecular weight natural antioxidants 
(antioxidant vitamins and polyphenols) and antioxidant enzyme systems. The enzymatic 
antioxidant defense include: superoxide dismutase (SOD) catalase (CAT) and glutathione 
peroxidases (GPRXs). These three enzymes act in a cooperative or synergistic way to ensure 
a global cell protection. To cope with ROS, cells express an array of antioxidant enzymes, 
including the superoxide dismutases (SOD) (e.g. cytosolic Cu/Zn- SOD, mitochondrial Mn- 
SOD and extracellular (Cu/Zn)- EC- SOD) which convert superoxide anions to hydrogen 
peroxide, that is then transformed to water by catalase (CAT) and by glutathione S-
peroxidase. When the balance between physiological ROS production and the antioxidant 
defences becomes unbalanced, this disequilibrium may drive the cell to cell death (Orrenius 
et al., 2007). 
Biological reactions that reduce the “harmful” levels of free radicals are of prime importance 
in reproductive systems in maintaining the quality of gametes and support reproduction. 
 We used a 48h in vitro model of human GLCs, to investigate how the supplementation with 
various concentrations of Cu, Zn – SOD or the treatment with various concentrations of Cu-
chelating agent sodium diethyldithiocarbamate (DDC) influences GLCs total SOD activity 
and the GLCs viability (Caspase-3 activity) and how these parameters are interrelated.  
The isolated GLCs from at least three women were cultured in 96- well plates (Linbro® Flow 
Labs, Virginia, USA), (50 μl/well). After 24 h culture period the cells were supplemented 
with 10, 100, 200 U/ml SOD1 (Cu, Zn-SOD, Inst. Microbiology, Bulg.Acad.Sci.) The purified 
Cu, Zn-SOD enzyme is a water-soluble homodimeric glycoprotein with a molecular mass of 
approximately 31700 Da and was isolated from Humicola lutea 103 (Krumova et al., 2007). 
The rest of cells without control were treated with 10, 100 µM DDC (Sigma). The Caspase-3 
activity was measured as mentioned above. The total SOD activity in GLCs at the end of the 
culture period (48 h), was measured according the method of Beaushap & Fridovich (1971).  
 Based on measured GLCs total SOD activity, anti-oxidative effect of low dose DDC (10µM) 
and pro oxidative effect of high dose DDC (100µM) were documented: significantly higher 
GLCs total SOD activity (10 µM DDC) and significantly lower GLCs total SOD activity (100 
µM DDC) was measured, respectively, compared to the control cells. 
The highest activity of Caspase-3, measured after the treatment with 100 µM DDC was 
followed by lowest total GLCs SOD activity, showing the direct role of Cu, Zn- SOD in the 
prevention of human GLCs from apoptosis. A possible cooperation of SOD and cytochrome 
C in mitochondria-dependent apoptosis has been described by Li et al 2006. The 
simultaneous release of SOD with cytochrome C has been shown to regulates mitochondria-
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dependent apoptosis increasing the susceptibility of mitochondria to oxidative stresses (Li et 
al 2009), whereas the active enzyme has been reported to be implicated in protecting vital 
mitochondria (Iñarrea et al., 2007). In this study for first time, we demonstrated that the 
supplementation with Cu, Zn-SOD (200 U/ml) was closely involved in anti-apoptotic 
mechanisms and maintains the human GLCs viability in vitro, by the suppression of 
Caspase-3 activity.  
3.6.2 Relationship between activity of antioxidant enzymes SOD and CAT in GLCs 
with COH / IVF outcome  
Oocytes and granulosa cells in all follicular stages are endowed with the major antioxidant 
and detoxifying enzymes (e.g. SOD and CAT) (Suzuki et al., 1999; Mouatassim et al., 1999). 
SOD activity and CAT activity have been demonstrated in human FFls (Carbone et al., 2003; 
Pasqualotto et al. 2009; Bausenwein et al., 2010). The expression of SOD and of CAT at 
mRNA and protein level have been studied in human follicular somatic cells, such as GLCs 
and CCs in relation to female reproductive aging and successful outcome of assisted 
reproductive technologies, respectively (Tatone et al., 2006; Matos et al., 2009). The aim of 
our study was to investigate the relationship among the activity of superoxide dismutase 
(SOD) and catalase (CAT) in GLCs and apoptosis of these cells with the results of COH/ IVF 
in infertile women. 
For detection of apoptosis in GLCs the method of DAPI-DNA staining was used. The 
activity of intracellular SOD and CAT of GLCs were measured using the Beaushap & 
Fridovich; Beers & Sizer methods, respectively (Beers & Sizer, 1952; Beaushap & Fridovich, 
1971). 
We studied the relationship between the activity of SOD and CAT in GLCs with the level of 
apoptosis (% apoptotic hGLCs) and with the parameters of COH and IVF. The balance 
between the ROS production, cellular antioxidant defenses, activation of stress-related 
signaling pathways, and the production of various gene products, will determine whether a 
cell exposed to an increase in ROS will be destined for survival or death (Kregel & Zhang, 
2007). The SOD and CAT play a central role in the antioxidative defense in the ovary and 
they act in tandem to neutralize the supra physiologic levels of ROS.  
Within the studied patient’s groups we found that the “health” status of human GLCs (low 
level of apoptosis) is associated positively with both, SOD and CAT activity in GLCs 
obtained from the same woman.  
Oxidative stress in granulosa cells was suggested to decrease both fertilization rate and 
quality of embryos in IVF cycles (Seino et al., 2002). Elevated level and high activity of SOD 
are associated with better quality of oocyte, and good embryo development, influenced, 
probably, by the oxidant/antioxidant (du Plessis et al., 2008). Our results demonstrated that 
the better outcome in the COH/IVF cycles, such as higher numbers of retrieved and 
fertilized oocytes are related to higher intra cellular SOD activity in GLCs. We consider that 
the intra cellular SOD activity in GLCs has contribution to the vital oocyte 
microenvironment, supported also by SOD activity in cumulus-oophorus cells (Matos et 
al., 2009) as well as by SOD and CAT activity of FFls (Kably Ambe et al., 2005; Pasqualotto 
et al., 2009), and that intra cellular SOD activity could be a potential biomarker for ART 
success. 
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4. Gene expression in cumulus cells as biomarker for oocyte competence 
Pregnancy and birth rates in assisted reproductive technology (ART), following in vitro 
fertilization (IVF) are unique events but unfortunately 2 out of 3 IVF cycles fail to result in 
pregnancy. Due to the subjective morphological parameters in selection of healthy embryos 
used in IVF and ICSI programmes, 8 out of 10 transferred embryos fail to implant 
(Kovalevsky, G. & Patrizio, P., 2005). Consequently, selecting oocytes with normal 
developmental competence and embryos with the highest implantation potential is of great 
importance in assisted reproductive technology.  
4.1 Cumulus cells as targets of biomarkers 
Ovarian follicle development and maturation are complex processes, involving both the 
oocyte and its surrounding transcriptionally distinct CCs and GLCs (Eppig et al., 2001). 
Mammalian oocyte growth and development is critically dependent on the functional two-
way communication axis that exists between the germ cell and its immediate companions – 
the ovarian cumulus cells. This communication is in form of direct gap-junction 
communications and paracrine signaling mediated via soluble oocyte-secreted factors 
(McNatty et al., 2004). It is well recognized now, that the oocytes also promote cumulus and 
granulosa cell proliferation, differentiation and apoptosis, suggesting that the health and 
function of the granulosa and cumulus cells being may be reflective of the health status of 
the enclosed oocyte (Eppig et al., 2001). Since the CCs and GLCs transcriptomic profiles are 
influenced of the bidirectional oocyte-somatic cells communication, and thus these profiles 
could serve as an approximate reflection of the oocyte developmental competence. 
Perturbations in the oocyte functionality both genetic and functional would result in an 
altered oocyte-cumulus signaling and thus an altered cumulus transcriptome. In this way, 
the study of the CCs transcriptomic profile offers the opportunity, by a non-invasive 
method, to predict oocyte and eventually embryo competence (Assou et al., 2010). 
Derived from this paradigm, we believe that after clinical validation a small subset of 
particular genes would render relatively cheap and non-invasive test for screening of good 
competence oocytes in all cases when ART procedures are involved, but pre implantation 
genetic diagnostic (PGD) of succeeding embryo might be not available or should be 
avoided.  
We have recently investigated several gene transcript products as part of larger set of 
cumulus-derived oocyte competence-predicting genes as a pilot evaluation study and prove 
of concept, namely: lysyl oxidase (LOX), basigin (BSG), phosphoglycerate kinase 1 (PGK1) 
and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) (Todorova et al., 
2011a, 2011b). We have also studied known protein transcriptional factors that might also 
impact the oocyte competence in case of altered abundance, perturbing the oocyte 
development, maturation or fertilization, and thus the oocyte fertility competence.  
4.2 The study concept of the transcript biomarkers 
Specimens from multiple oocyte-neighboring cumulus cells were isolated from three 
investigated patients’ groups: women with reproductive problems, participating in ICSI 
procedures with primary sterility; women with reproductive problems, participating in ICSI 
procedures with secondary sterility; women with so called “male factor sterility” (where 
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reproductive failure is result in male infertility) and women who participated in “healthy 
donors” in vitro programs. All three groups of women were subject to hormonal stimulation 
short or long protocols, involving at least FSH and Progesterone.  
A quantitative reverse transcriptase real-time PCR approach was applied to estimate the 
differential gene expression levels of the LOX and BSG gene transcripts, normalized to the 
house keeping gene PGK1, in the cumulus cells surrounding acquired oocytes from ICSI-
targeted primary and secondary sterility IVF patients and healthy fertile donors.  
After separation of the CCs from each acquired oocyte, the specimens were individually 
collected and they were subject to consecutive lysis, mRNA extraction, reverse transcriptase 
gene specific cDNA synthesis and PCR amplification. For this approach we utilized the one 
step Fastlane Cell RT-qPCR Kit (Qiagen, USA). The assays were run on a qPCR Cycler 
(Agilent Technologies MX3005P, Stratagene, USA) using the exact thermal protocol supplied 
by the manufacturer. The primers were produced by Biomers, Germany.  
The data obtained by the qPCR reaction were subsequently subject to analysis by Stratagene 
MxPro software and represented as gene transcript fold change, where donor specimens 
were set as 0 fold change. The subsequent statistical analyses included non-parametric 
Kruskal-Wallis non-parametric ANOVA on the normalized expression levels of lox and bsg, 
expressed as fold change compared to donor expression.  
We used pgk1 as housekeeping normalizing gene since it is a transferase enzyme that in 
humans is involved in main biochemical pathway – the glycolysis, transferring a phosphate 
group from 1,3-biphosphoglycerate to ADP, with formation of ATP and 3-Phosphoglycerate 
(Singer-Sam et al., 1984). It has been also considered as suitable housekeeping gene for the 
cumulus cells as it is found in all living organisms and its sequence has been highly 
conserved throughout evolution (Kumar et al., 1999). 
4.3 The putative markers 
Lysyl oxidase also known as protein-lysine 6-oxidase is a protein that, in humans, is encoded 
by the LOX gene. Its upregulation by tumor cells may promote metastasis of the existing 
tumor, causing it to become malignant and cancerous (Hämäläinen et al., 1991). This 
enzyme oxidized peptidyl lysine to pepttidyl aldehyde residues within collagen and elastin, 
initiating formation of the covalent cross-linkages that insolubilize these extracellular 
proteins (Li et al., 1997). This function of LOX made it implicated so far in both ovary 
extracellular matrix synthesis and to some extent in policistic ovary cystogenesis in rat 
models as well (Papachroni et al., 2010). LOX was found to be under endocrine, paracrine, 
and autocrine control, with FSH being major coordinator of its response to these stimuli 
(Harlow et al., 2003). 
Jiang et al., 2010 investigated whole genome gene expression profiling of mural granulosa 
cells and the authors demonstrated that mural granulosa cells isolated from follicles 
containing oocytes with normal developmental competence are distinct from those with 
oocytes exhibiting poor developmental competence. These authors established that there 
were genes which profiles are different in two investigated groups. They reported lox 
expression to be 2.8-fold higher in mural granulosa cells isolated from follicles containing 
oocytes which exhibit normal developmental competence when compared with poor ones. 
These results were validated by real-time PCR (Jiang et al., 2010). 
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Our data are in controversy with the above findings observing quite the opposite 
phenomenon - LOX mRNA expression estimated with comparative quantitative real-time 
PCR (2-ΔΔCt method) was almost 4.32-fold higher (mean value) in infertile women with 
primary sterility and reproductive failure, compared to fertile donors. LOX mRNA is up-
regulated in women with primary or secondary sterility. The difference observed in women 
with secondary sterility was also increased in favor of the donors - 3.85. (Todorova et al., 
2011a, 2011b). We believe that one possible explanation would be that in the above 
mentioned study (Jiang et al., 2010) immature rats were subject of an anti-eCG treatment 
with subsequent induction of apoptosis in the granulosa cells, and folliclar atresia, an effect 
that they report as antibody dose-dependent. In our study design (Todorova et al., 2011a, 
2011b) human subjects were studied and even though they could have varying degree of 
hormone levels, those are both medication stimulated, and followed as feedback, and no 
patient participates in ART program unless normal (target range) hormone levels are 
achieved, and latter normal oocyte morphology is prerequisite for subsequent IVF/ICSI 
procedure. The observed LOX levels are most likely related to the stimulation protocol that 
induced follicle maturation (GnRH or FSH) and later on - oocyte maturation (hCG) and 
ovulation. FSH and hCG (eCG) were found to downregulate LOX gene expression. 
Therefore it should be expected that in the cumulus cells of fertile women and healthy 
donors rather decreased lox mRNA transcript levels would be observed. Parallel to that, the 
lox gene expression is able to suppress oocyte maturation in experimental model systems, 
suppressing both RAS and Progesterone induction (Di Donato et al., 1997). Thus some 
subtle differences between donor’s and IVF/ICSI failure oocytes exist, that are neither 
directly reflected by the woman hormonal levels, nor by the oocyte parameters alone. 
Besides in Jiang et al., 2010 study mural granulosa were analyzed, rather than human 
cumulus cells.  
It has to be noted that there is growing evidence for functional difference in transcriptomes 
expressed in the oocyte adjacent cumulus cells and the granulosa cells located further on. 
Although morphologically they may seem the same, the existence of paracrine signaling axis 
between oocyte and adjacent somatic cells creates a signaling molecules concentration 
gradient that renders different responses and hence distinct expression profiles in the 
somatic cells across the oocyte follicle. Whether there are more stable and long lasting 
differences remains yet to be established. 
A more in depth analysis of oocyte physiology reveals that LOX has been shown to 
participate in very important processes connected with the cell differentiation of granulosa 
cells (Jiang et al., 2010). TGF-ǃ1 and GDF9 increase lox mRNA expression in rat granulosa 
cells (Kendall et al., 2003). The GDF9-induced preantral follicular growth in vitro involves 
increased mural granulosa cell lox mRNA expression (Assou et al., 2010), and similarly the 
investigations on rat granulosa cells showed that lox transcripts were significantly 
suppressed 48h after eCG injection compared with untreated controls (Jiang et al., 2010). 
Harlow et al. demonstrated that while in primary and especially in preantral follicle GDF-9 
increases extremely LOX expression, in antral follicle in which the levels of FHS-receptors 
are induced, FSH dose-dependently decreases the LOX levels, while GDF-9 induction effect 
is diminished. In this context the lox mRNA and protein expression levels should be 
expected to be decreased, rather than increased (Harlow et al., 2003). This could serve as 
legitimate explanation, why in women with infertility the levels of lox mRNA are actually 
increased, with highest levels in those who are having primary sterility.  
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Basigin is a member of the immunoglobulin superfamily that is also known as EMMPRIN, 
short for extracellular matrix metalloproteinase inducer (Miyauchi et al., 1992). BSG has 
already been shown to be expressed in the ovary and play key roles in fertility. It appears to 
be critical for both ovulation and implantation. BSG plays fundamental roles in various 
immunologic phenomena, differentiation, development and intercellular recognition. 
Knock-out of BSG in mice results in infertility in both sexes. It was demonstrated that bsg 
gene disruption produces failure of female reproductive processes affecting both 
implantation and fertilization (Kuno et al., 1998). BSG mRNA expression in cumulus cells 
and basolateral localization of the BSG protein in the endometrial epithelium further 
support the importance of BSG in these processes (Smedts, A., & Curry, T. (2005). Our data 
showed an increase of approximately 6.5 fold for BSG in primary sterility women compared 
to the fertile donors (Todorova et al., 2011a, 2011b). The difference observed in women with 
secondary sterility was also increased in favor of the donors - 2.5 for BSG. Correlation 
statistical analysis applied to the fold-change expression rates of LOX vs. BSG using the data 
acquired for every single specimen of cumulus cells suggested although low power, but 
positive correlation between the lox and bsg gene expression levels. The Coefficient of 
determination (r2) as measure of the significance of the correlation between LOX and BSG 
was 0.5. 
4.4 The study concept of the transcriptional factor NFκB involvement 
Protein lysates from the same oocyte neighboring cumulus cells were subject to SDS-PAGE 
and subsequent Western blotting for specific antibody-mediated immunological detection of 
activated NFκB transcription factor. Lysates from cumulus cells were run under reducing 
conditions in a 12% SDS-PAGE gel. The separated proteins were transferred to a 
polyvinylidene fluoride membrane (Sigma, St. Louis, MO, USA). The membranes were 
blocked and then incubated with anti-NFκB antibody (R&D, USA). The membranes were 
washed and incubated with anti-mouse ALEXA 488 antibody conjugated. The Western blots 
were visualized by fluorescent scanner - Ethan DIGE (General Electric, USA), using 
membrane scanning protocol and appropriate for ALEXA 488 exposure times of the Cy2 
preset channel in the acquisition software. 
NFκB is a protein complex that controls the transcription of DNA. NF-κB is found in almost 
all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, 
free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB 
plays a key role in regulating the immune response to infection (Gilmore et al., 2006). Resent 
study has shown that LOX has a binding domain for NFκB making it a putative binding 
partner and interactor (Li, D., & Mehta J. 2000.; Chen et al., 2006).  
As a provisionary Western blot suggest, there is distinct protein level expression of NF-κB 
among the investigated groups of fertile vs infertile women. Immunoblotting with anti-
NFκB antibody demonstrated elevated levels of active NFκB in women with reproductive 
failure, while in donors this stress molecule was not nuclear translocated and detectable. 
The expression was higher in women with secondary sterility compared to those, (subject to 
ICSI,) with primary sterility (Todorova et al., 2011). It is controversial why NFκB is increased 
mostly in secondary sterility patients, since it is stress and inflammation related transcriptional 
factor, but it has to be noted, that a lot of paracrine singling is mediated by interleukins, and 
other factors released after NFκB nuclear translocation (Paciolla et al., 2011). 
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The quality of the oocyte is largely dependent on its follicular environment. Developmental 
competence of the oocytes is a major determinant in the establishment of successful 
pregnancy in assisted reproduction. The primary criterion for oocyte selection in the human 
fertility clinic is the morphological characteristics of oocytes that is highly biased and does 
not accurately predict the quality of the oocyte (Ebner et al., 2003). Many studies reported 
that cumulus and granulosa cell gene expression is associated with oocyte health and 
development (Assou et. al., 2010). 
Our studies on LOX expression profile in human cumulus cells is the first investigation ever 
done on human subjects. Our findings suggest that LOX, and to lesser extent BSG may 
prove first step and prove of concept as future screening panels incorporated markers for 
oocyte developmental competence. An ongoing research is currently in progress to confirm 
our suggestion and extend the suggested panel.  
5. Conclusion 
The study of the ovarian function in the context of both innate to adaptive immunity 
interaction and the role of such fundamental processes as apoptosis and oxidative stress 
challenge with their arising complexity and multimodality. We believe that our research will 
contribute to the discussed in this text long term exploration of the ovarian biology and 
immunology by the reproductive biology scientific community, providing us with an 
insight and new clues regarding the non-invasive evaluation of the biological fertility 
potential and future technological aids in favor of the reproductive medicine. We believe 
that these infertility biomarkers will prove significant capacity as fertility and oocyte 
competence predictors. 
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